For the quarter ending 2025-09-30, CALC has $14,913K in assets. $15,181K in debts. $5,470K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,470 | 5,918 | ||
| Short-term investments | 8,614 | 12,039 | ||
| Prepaid clinical trial expenses | 230 | 352 | ||
| Other prepaid expenses and current assets | 539 | 655 | ||
| Total current assets | 14,853 | 18,964 | ||
| Property and equipment, net | 49 | 105 | ||
| Other assets | 11 | 11 | ||
| Total assets | 14,913 | 19,080 | ||
| Accounts payable | 1,133 | 1,912 | ||
| Accrued clinical trial costs | 1,523 | 670 | ||
| Accrued expenses | 1,025 | 895 | ||
| Total current liabilities | 3,681 | 3,477 | ||
| Promissory note | 8,900 | 8,500 | ||
| Warrant liability | 2,600 | 1,000 | ||
| Total liabilities | 15,181 | 12,977 | ||
| Common stock, 0.0001 par value 500,000,000 shares authorized at september 30, 2025 and december 31, 2024, respectively 14,257,234 and 13,481,917, issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in capital | 178,293 | 176,865 | ||
| Accumulated deficit | -178,566 | -170,762 | ||
| Accumulated other comprehensive income | 1 | -4 | ||
| Total stockholders' equity (deficit) | -268 | 6,103 | ||
| Total liabilities and stockholders' equity | 14,913 | 19,080 | ||
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)